ClinicalTrials.gg
Not yet recruitingNCT07632027BAROLOUpdated Oct 23, 2026

Bedside Assessment of Right Ventricular Output Lying in Prone Or Supine

An interventional study of Prone position in Right Ventricular Function, Prone Position and Atelectasis, sponsored by Sahlgrenska University Hospital. Not yet recruiting at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-23.

Sponsored by Sahlgrenska University Hospital · Not applicable, Interventional, and Treatment

How we know

Updated Oct 23, 2026Eligibility revisedStart date moved+6 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 16 studies in Pulmonary Atelectasis with a site in Sweden — 5 open to participants now, 5 under way, none of them phase 3. Pulmonary Atelectasis · Sweden.

Planned enrollment
2nd of 10
70 · median 30
Started
2026
with 1 other
No phase
10 of 16
3 open now
Registered
15th of 16
by date
Lead sponsor
2 of 16
Sahlgrenska University Hospital

Among the 16 studies in Pulmonary Atelectasis with a site in Sweden, this one is the 2nd largest by planned enrollment of the 10 interventional ones that give a count, is one of 2 that started in 2026, is one of 10 with no phase, and was the 15th registered.

Pulmonary Atelectasis

378 studies on the registry are indexed under Pulmonary Atelectasis; 91 are open to participants now.

Browse Pulmonary Atelectasis studies →

Open to participants now

5 of the 16 studies in Pulmonary Atelectasis with a site in Sweden are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →

Who these studies take

Of the 51 Pulmonary Atelectasis studies recruiting now, 20 (39%) set no upper age limit and 23 (45%) stop at 75 or younger; 24 take children under 18; 2 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 16 studies in Pulmonary Atelectasis with a site in Sweden, or all of them as a file.
02

Study summary

Right ventricular failure (RVF) is a common complication to cardiac surgery, which is associated to mortality, kidney failure, stroke, prolonged mechanical ventilation and ICU stay. The right ventricle is particularly vulnerable to an increased afterload. By increasing pulmonary vascular resistance (PVR), atelectasis might mitigate a negative effect on the right ventricle.

Recruitment maneuvers have been shown to resolve atelectasis and improve hemodynamics by increasing cardiac output and lowering PVR. However these maneuvers transiently raise airway pressures, which in turn increases right ventricular afterload, a situation often poorly tolerated by patients with RVF.

Prone position is used in patients with respiratory failure and has been shown to decrease mortality in patients with ARDS. Prone position decreases atelectasis and moves ventilation dorsally. In ARDS it also seems to mediate beneficial hemodynamic effects such as an increase in cardiac output and a decrease in PVR.

The investigators hypothesis is that prone position early after cardiac surgery will increase cardiac output by recruitment of atelectasis and thereby decrease PVR.

Read the detailed description

Recruitment and consent:

Patients will be screened for participation no later than the day before surgery. Potential participants will be given written and verbal information regarding the study and time to ask questions and consider their participation.

Randomization:

After end of surgery, at baseline in the ICU, patients will be randomly allocated (1:1 ratio) to supine position and prone position. Block randomization with variable block sizes will be performed with sequentially numbered, opaque, sealed envelopes. All performed by Statistiska konsultgruppen. Patient stratification according to cardiac index at end-surgery will be performed to ensure similar allocation of patients with cardiac index \<2.2 L/min/m2 in each group. The investigator who enrolls study participants will not have access to the random allocation sequence.

Sample Size:

Based on previous studies of cardiac surgery or prone position an a priori sample size calculation was performed using a two-sample t-test comparison of means, with equally sized independent groups. With intention to detect at least a 20% difference in cardiac index in the intervention group and with 80% power, 0.05α, estimated mean CI 2.6(0.9 SD) in control group, and CI 3.2(0.9 SD) in the prone group, the estimated sample size was n=70, divided in 2 equally large groups. As patients intermittently require recurring surgery due to i.e. bleeding, patients might be excluded after inclusion. Enrolment continues until 70 participants have completed the entire study protocol.

Interim analysis:

Given uncertainty regarding expected baseline cardiac index and its standard deviation in the study population, an interim sample size reassessment will be performed after inclusion of 40% of the planned sample (n=28). The interim analysis will be limited to re-estimation of mean and standard deviation of baseline cardiac index, and will not assess treatment effects. If the observed assumptions differ substantially from those used in the original sample size calculation, the required sample size may be adjusted to preserve the planned statistical power of the study.

Description of method:

In included patients, anesthesia will be performed with Propofol, Fentanyl and Sevoflurane. As per clinical routine patients will have a central venous catheter, 1-2 arterial catheters, TEE probe and endotracheal tube inserted. Study participants will also get a pulmonary artery catheter (PAC) inserted prior to surgery to facilitate measurement of cardiac output using thermodilution and PVR. Body surface area is calculated using the Mosteller formula.

During surgery, after CPB is weaned, the attending anaesthesiologist is instructed to refrain from additional recruitment maneuvers and a PEEP >8 cmH2O. Unless FiO2 is >80% to maintain adequate oxygenation of the patient or the anaesthesiologist deems it necessary.

When surgery is finished, the patient will be moved to the Thoracic ICU. Ventilation performed with a Maquet Servo-U (Getinge, SE) is set to volume control, tidal volumes of 6 ml/kg IBW with a respiratory rate of 12-18 and PEEP 8 cmH2O. Data collection occurs in all patients in supine position (0). Hereafter the study group is turned to prone while the control group remains in supine position.

60 minutes after proning data is again collected (t1), whereafter a recruitment maneuver is performed by gradually increasing PEEP during 2,5 minutes in 6 steps to 20 cmH2O during. After 30 seconds PEEP is decreased in 6 steps during 2,5 minutes to reach PEEP 8 cmH2O. Data is collected after the recruitment maneuver (t2) and one hour after (t3), adding up to a total of 2 hours and 15 minutes in supine or prone position. The patients in prone position are turned to supine position and the last data collection occurs (t4). In total 5 time points for data collection. Postoperative care will now continue as per routine care. Patients will be extubated as soon as possible according to clinical routine and eventually discharged from the ICU.

Since a recruitment maneuver transiently increases right ventricular afterload there is a possibility not all patients will tolerate the recruitment maneuver as described above. As per clinical practice the level of airway pressures during recruitment will be adjusted when needed to avoid adverse effects.

Discontinuation of the intervention:

In order to minimize harm the following set criteria will be used to discontinue prone position:

  • Hemodynamic instability with increased Norepinephrine >0.7mcg/kg/min
  • Sustained arrythmia which requires treatment including DC conversion
  • Any condition which, in the judgement of the investigator, might increase risk of harm to the patient

Blinding:

After allocation to supine or prone position neither the investigator, nor ordinary ICU personnel, will be blinded due to safety and impracticalities. Patients are blinded due to being under general anaesthesia during randomization until weaning from mechanical ventilation (after the study protocol is completed).

Data collection:

A site investigator will record data using a software developed by Getinge from the respirator to a designated research computer. All other data and variables, mentioned above, will be collected from the participants digital chart and real time monitoring (Philips IntelliVue \& BD Hemosphere).

Data management:

Collected data is pseudonymized and stored on a password protected designated research computer. Only authorized study personnel have access to the computer.

Original records, including signed written consent, are kept with strict confidence. These records will be kept in a secure, locked and limited access location at Sahlgrenska Univeristy Hospital during the study and after completion for an additional 10 years. At inclusion each patient is pseudonymized by receiving a participant ID, which is used in all data files.

03

Conditions studied

  • Right Ventricular Function
  • Prone Position
  • Atelectasis
  • Atelectases, Postoperative Pulmonary
  • Cardiac Output
  • Vasoconstriction
  • Heart Failure
  • Recruitment Maneuver
  • Respiratory Mechanics
  • Pulmonary Arterial Pressure
  • Cardiac Surgery
  • Cardiac Surgery Recovery
  • Cardiopulmonary Bypass
04

Who can participate

The criteria were revised on the registry on Oct 23, 2026. See what changed

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Scheduled for cardiac surgery using cardiopulmonary bypass

Exclusion criteria

Exclusion Criteria:

  • >40
  • Emergency surgery
  • Severe pulmonary disease
  • Haemodynamic instability requiring Norepinephrine >0.5mcg/kg/min
  • Intracardiac shunt
  • Severe (or worse) tricuspid regurgitation
  • Any condition which, in the judgement of the investigator, might increase the risk to the patient
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
70 participants (estimated)

Study arms

  • No intervention
    Supine position

    Control group. Will remain in supine position for the whole protocol.

  • Experimental
    Prone position

    Will be turned to prone position after baseline data collection (0) and return to supine position before the final data collection (t4).

    Procedure: Prone position

Interventions

  • ProcedureProne position

    Prone position is applied in the intervention group immediately after randomization, patients will be prone for a total of 2 hours and 15 minutes. During this time 3 data collection points occur (t1, t2 \& t3).

06

What researchers measure

Primary outcomes

  1. Cardiac Index

    L/min/m2

    Time frame: 1 hour after baseline

Secondary outcomes

  1. PVRi

    Difference between and within groups

    Time frame: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.

  2. Cardiac Index

    Difference between and within groups

    Time frame: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.

  3. RV pressure

    Looking at differences of right ventricular blood pressure between groups at all timepoints

    Time frame: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.

  4. Driving Pressure

    Plateau Pressure - PEEP

    Time frame: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.

  5. PaO2:FiO2

    Within and between groups

    Time frame: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.

  6. Vasopressor dose

    Difference of actual vasopressor dose within and between groups at all timepoints

    Time frame: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.

  7. Inotrope dose

    Difference of actual inotrope dose between groups at all timepoints

    Time frame: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.

  8. CVP

    Difference in central venous pressure within and between groups at all timepoints

    Time frame: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.

  9. PAP

    Difference in pulmonary artery pressure within and between groups at all timepoints

    Time frame: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.

  10. PCWP

    Difference in pulmonary capillary wedge pressure within and between groups at all timepoints

    Time frame: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.

  11. Systemic blood pressure

    Difference in systemic blood pressure within and between groups at all timepoints

    Time frame: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.

  12. Heart rate

    Difference in heart rate within and between groups at all timepoints

    Time frame: 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.

  13. Chest drain output

    Total amount from all chest drains between Baseline and t4.

    Time frame: 2 hours 45 minutes after baseline

  14. ICU length of stay

    Time from start to end of the ICU visit, measured in days.

    Time frame: Perioperative

  15. Time to extubation

    Time from arrival to the ICU until patient's endotracheal tube is removed (extubation). Measured in hours.

    Time frame: Perioperative

  16. Harms

    Adverse events. Severity graded: Mild, Moderate, Severe \& Life-Threatening. Causality: Due to prone position? Other reason?

    Time frame: At any point in time from Baseline to 2 hours and 45 minutes after Baseline.

Other outcomes

  1. RV contractility during recruitment maneuver

    Measured as dP/dt (mmHg/s). Maximum upslope of the pressure waveform measured at the RV.

    Time frame: During recruitment (1 hour after baseline).

  2. Physiological dead space

    Eventual exploratory outcome. Analysis of VD/VT using Enghoff-modified Bohr equations.

    Time frame: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.

  3. Subgroup analysis of Cardiac Index

    Patients with perioperative or postoperative diagnosed RVF according to a published standardized definition will be analyzed separately in a subgroup analysis.

    Time frame: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.

  4. Subgroup analysis of PVRi

    Patients with perioperative or postoperative diagnosed RVF according to a published standardized definition will be analyzed separately in a subgroup analysis.

    Time frame: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.

07

Study locations

1 site
  • Cardiothoracic Intensive Care Unit
    Gothenburg, 41345, Sweden
08

References and documents

Individual participant data

Plan to share: No — As of now there aren't any plans to share IPD. However if good ideas for further studies on this data by other researchers appear, our plan to share IPD might change.

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for May 2029, 31 months later.

Of 155 non-industry interventional studies with no phase under Pulmonary Atelectasis, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 24. This study's planned 31 months is above that.

Counting every sponsor, half of 157 studies reached it within 11 months; a quarter within 5 and three quarters within 21.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 13, 2026: start Sep 2026 → Oct 2026, primary completion May 2028 → May 2029 and completion Oct 2028 → Oct 2029.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Mar 24, 2026
First posted
Jun 8, 2026
StartEst.
Oct 2026was Sep 2026
Primary completionEst.
May 2029was May 2028
CompletionEst.
Oct 2029was Oct 2028
Last update
Oct 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
1 site added, 1 site removed
Show site
  • Cardiothoracic Intensive Care Unit · Gothenburg, Sweden
Show 1 removed
  • Cardiac Intensive Care Unit · Gothenburg, Sweden
Oct 13, 2026
Start date
Sep 2026→Oct 2026
Oct 13, 2026
Primary completion
May 2028→May 2029
Oct 13, 2026
Study completion
Oct 2028→Oct 2029
Oct 13, 2026
Enrollment
80→70
Oct 13, 2026
Eligibility
Criteria revised in 2 updates
What changed on Oct 13, 2026
Exclusion criteria
  • RemovedIn need of secondary surgery
  • EditedAdvanced grown -up congenital heart disease
  • EditedPulmonarySevere pulmonary disease
  • EditedHemodynamicHaemodynamic instability withrequiring Norepinephrine >0.4mcg5mcg/kg/min
  • AddedIntracardiac shunt
  • AddedSevere (or worse) tricuspid regurgitation
What changed on Oct 23, 2026
Exclusion criteria
  • RemovedAdvanced grown-up congenital heart disease
across 2 updates, Oct 13, 2026 – Oct 23, 2026
Secondary outcomes
2 added, 1 removed
What changed in the outcomes
  • AddedChest drain outputTime frame: 2 hours 45 minutes after baseline
  • AddedHarmsTime frame: At any point in time from Baseline to 2 hours and 45 minutes after Baseline.
  • RemovedAdverse eventsTime frame: At any point in time from Baseline to 2 hours and 45 minutes after Baseline.
Oct 13, 2026
Title
Bedside Assessment of Right Ventricular Output Lying in Prone Or Supine Position
Oct 13, 2026
Show all 2 updates
  1. Oct 23, 2026
    Eligibility 1 exclusion criterion removed
    What changed in the criteria
    Exclusion criteria
    • RemovedAdvanced grown-up congenital heart disease
    + 2 other changes: identifiers and description
  2. Oct 13, 2026
    1 site added, 1 site removed
    Show site
    • Cardiothoracic Intensive Care Unit · Gothenburg, Sweden
    Show 1 removed
    • Cardiac Intensive Care Unit · Gothenburg, Sweden
    Start date Sep 2026→Oct 2026
    Primary completion May 2028→May 2029
    Study completion Oct 2028→Oct 2029
    Enrollment 80→70
    Eligibility 3 exclusion criteria edited, 2 added, 1 removed
    What changed in the criteria
    Exclusion criteria
    • RemovedIn need of secondary surgery
    • EditedAdvanced grown -up congenital heart disease
    • EditedPulmonarySevere pulmonary disease
    • EditedHemodynamicHaemodynamic instability withrequiring Norepinephrine >0.4mcg5mcg/kg/min
    • AddedIntracardiac shunt
    • AddedSevere (or worse) tricuspid regurgitation
    Secondary outcomes 2 added, 1 removed
    What changed in the outcomes
    • AddedChest drain outputTime frame: 2 hours 45 minutes after baseline
    • AddedHarmsTime frame: At any point in time from Baseline to 2 hours and 45 minutes after Baseline.
    • RemovedAdverse eventsTime frame: At any point in time from Baseline to 2 hours and 45 minutes after Baseline.
    Title Bedside Assessment of Right Ventricular Output Lying in Prone Or Supine Position
    + 2 other changes: verification date and description

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07632027
Responsible party
Viktor Erbring (Principal Investigator, MD, PhD student, Consultant in Cardiothoracic Anaesthesia and Intensive Care., Sahlgrenska University Hospital) — Principal investigator
First posted
Jun 8, 2026
Start date
Oct 2026 (estimated)
Primary completion
May 2029 (estimated)
Completion
Oct 2029 (estimated)
Last update
Oct 23, 2026

Study contacts

Viktor Erbring, MD
Contact
viktor.erbring@vgregion.se
+46706456664
Per Persson, MD, PhD
Contact
per.persson@vgregion.se
+46736467042

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion